Solomennchuk T M, Slaba N A, Prots'ko V V, Bedzaĭ A O
Wiad Lek. 2014;67(2 Pt 2):254-7.
The aim of this research was the study of efficiency and endurance antihypertensive therapy on the basis of fixed combination of enalapril and hydrochlorothiazide (HCTZ) and enalapril and HCTZ in combination with amlodipine according to the twenty-four-hour (? day-and-night) monitoring of blood pressure (? 24H BPM) of patients with arterial hypertension (AH) 2-3 severity. The study included 33 patients with 2-3 grade of hypertension (average age--54,40 ± 3.45 years). All patients performed ? 24H BPM before treatment and after 12 weeks of therapy. The combination of enalapril and HCTZ allowed to achieve target levels of blood pressure in 79% of patients, amlodipine additional purpose--in 86% of patients. We found that this therapy has a corrective effect on daily blood pressure profile, significantly reducing the load pressure and blood pressure variability. During treatment with the combination of enalapril and HCTZ combination of enalapril, HCTZ with amlodipine optimal daily profile of blood pressure after 12 weeks of reaching respectively 63.1% and 71.4% of patients. The treatment with combination of enalapril and HCTZ and adding of amlodipine is characterized by good endurance and high adherence to treatment.
本研究的目的是,基于依那普利与氢氯噻嗪(HCTZ)的固定组合以及依那普利、HCTZ与氨氯地平联合用药,针对2-3级严重程度的动脉高血压(AH)患者的血压进行24小时(昼夜)监测,研究降压治疗的效果和耐受性。该研究纳入了33例2-3级高血压患者(平均年龄54.40±3.45岁)。所有患者在治疗前及治疗12周后均进行了24小时血压监测。依那普利与HCTZ联合用药使79%的患者达到了血压目标水平,加用氨氯地平后这一比例为86%。我们发现,这种治疗方法对每日血压曲线具有校正作用,可显著降低负荷血压和血压变异性。在使用依那普利与HCTZ联合用药以及依那普利、HCTZ与氨氯地平联合用药治疗期间,12周后分别有63.1%和71.4%的患者达到了最佳的每日血压曲线。依那普利与HCTZ联合用药并加用氨氯地平的治疗方法耐受性良好,患者对治疗的依从性高。